High Seroprevalence of Human Herpesviruses in HIV-Infected Individuals Attending Primary Healthcare Facilities in Rural South Africa
暂无分享,去创建一个
James A. McIntyre | Sarah Getu | Albert D. M. E. Osterhaus | A. Osterhaus | J. McIntyre | G. Verjans | R. Peters | H. Struthers | S. Getu | Erik Schaftenaar | Georges M. G. M. Verjans | Helen E. Struthers | Remco P. H. Peters | E. Schaftenaar
[1] O. Opare-Sem,et al. Prevalence of persistent and latent viruses in untreated patients infected with HIV‐1 from Ghana, West Africa , 2009, Journal of medical virology.
[2] N. Hens,et al. Serology indicates cytomegalovirus infection is associated with varicella‐zoster virus reactivation , 2014, Journal of medical virology.
[3] S. Chakrabarti,et al. Incidence of multiple Herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario , 2010, Virology Journal.
[4] Jennifer S. Smith,et al. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. , 2002, The Journal of infectious diseases.
[5] C. Masuet-Aumatell,et al. Seroprevalence of varicella‐zoster virus infection in children from Cochabamba: tropical or temperate pattern? , 2012, Tropical medicine & international health : TM & IH.
[6] J. Brooks,et al. Prevalence and Risk Factors Associated With Herpes Simplex Virus-2 Infection in a Contemporary Cohort of HIV-Infected Persons in the United States , 2012, Sexually transmitted diseases.
[7] J. Baeten,et al. Characteristics of HIV-1 Discordant Couples Enrolled in a Trial of HSV-2 Suppression to Reduce HIV-1 Transmission: The Partners Study , 2009, PloS one.
[8] B. Stilwell,et al. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision. , 2006 .
[9] B. Wahrén,et al. Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[10] R. Nichols,et al. Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity , 2011, Epidemics.
[11] R. Hayes,et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations , 2001, AIDS.
[12] I. Mohr,et al. Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons. , 2010, Cell host & microbe.
[13] U. Schaad,et al. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity , 2001, The Pediatric infectious disease journal.
[14] U. Gyllensten,et al. A fas gene polymorphism influences herpes simplex virus type 2 infection in South African women , 2010, Journal of medical virology.
[15] B. Stray-Pedersen,et al. Herpes simplex virus type-2 and human immunodeficiency virus infections in a rural population in Kilimanjaro Tanzania. , 2011, East African journal of public health.
[16] A. Wald. Herpes simplex virus type 2 transmission: risk factors and virus shedding. , 2004, Herpes : the journal of the IHMF.
[17] L. Juárez-Figueroa,et al. Population-based prevalence of antibodies against herpes simplex virus type 2 and socio-demographic characteristics in Mexico. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[18] E. Kozlova,et al. Chronic herpesvirus reactivation occurs in aging , 2007, Experimental Gerontology.
[19] D. Consonni,et al. Relationship between prevalence rate ratios and odds ratios in cross-sectional studies. , 1997, International journal of epidemiology.
[20] Jeffrey N. Martin,et al. Substantial regional differences in human herpesvirus 8 seroprevalence in sub‐Saharan Africa: Insights on the origin of the “Kaposi's sarcoma belt” , 2010, International journal of cancer.
[21] H. Weiss,et al. Epidemiology of herpes simplex virus type 2 infection in the developing world. , 2004, Herpes : the journal of the IHMF.
[22] Neil Pearce,et al. Effect Measures in Prevalence Studies , 2004, Environmental health perspectives.
[23] K. Rajewsky,et al. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. , 2000, Immunity.
[24] J. Sinclair. Human cytomegalovirus: Latency and reactivation in the myeloid lineage. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[25] J. Kiecolt-Glaser,et al. Changes in Epstein-Barr Virus Antibody Titers Associated with Aging , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[26] J. Goodwin,et al. Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age , 2012, Journal of medical virology.
[27] E. Gouws,et al. HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour , 2001, AIDS.
[28] Craig S. Miller,et al. High Prevalence of Multiple Human Herpesviruses in Saliva from Human Immunodeficiency Virus-Infected Persons in the Era of Highly Active Antiretroviral Therapy , 2006, Journal of Clinical Microbiology.
[29] J. Kempen,et al. Ocular immune reconstitution inflammatory syndromes , 2008, Current opinion in HIV and AIDS.
[30] J. Torres,et al. Susceptibility to varicella-zoster infection in individuals 1 to 29 years of age in Mexico. , 1999, Archives of medical research.
[31] E. Sanders,et al. Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya , 2011, BMC infectious diseases.
[32] S. Esser,et al. Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis , 2013, BMC Infectious Diseases.
[33] A. Oxenius,et al. Impact of antigen specificity on CD4+ T cell activation in chronic HIV-1 infection , 2013, BMC Infectious Diseases.
[34] A. Trkola,et al. HIV-1 replication activates CD4+ T cells with specificities for persistent herpes viruses , 2010, EMBO molecular medicine.
[35] S. Staszewski,et al. Prevalence- and Gender-Specific Immune Response to Opportunistic Infections in HIV-Infected Patients in Lesotho , 2010, Sexually transmitted diseases.
[36] A. Flahault,et al. Micro and macro population effects in disease transmission: the case of varicella , 2009, Epidemiology and Infection.
[37] A. Molesworth,et al. Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub-Saharan Africa , 2012, Tropical medicine & international health : TM & IH.
[38] A. Adjei,et al. Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa , 2008, BMC infectious diseases.
[39] P. Klenerman,et al. Viral coinfections among African children infected with human immunodeficiency virus type 1. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.